Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)

BACKGROUND: Treatment of spasticity poses a major challenge in amyotrophic lateral sclerosis (ALS) patient management. Delta-9-tetrahydrocannabinol (THC):cannabidiol (CBD) oromucosal spray (THC:CBD), approved for the treatment of spasticity in multiple sclerosis, serves as a complementary off-label...

詳細記述

保存先:
書誌詳細
出版年:BMC Neurol
主要な著者: Meyer, Thomas, Funke, Andreas, Münch, Christoph, Kettemann, Dagmar, Maier, André, Walter, Bertram, Thomas, Annett, Spittel, Susanne
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2019
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6732193/
https://ncbi.nlm.nih.gov/pubmed/31493784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-019-1443-y
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料